Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection

被引:12
|
作者
Hsu, CC [1 ]
Chen, JJ [1 ]
Hu, TH [1 ]
Lu, SN [1 ]
Changchien, CS [1 ]
机构
[1] Chi Mei Fdn Hosp, Dept Internal Med, Div Gastroenterol, Tainan 710, Taiwan
关键词
H-2-receptor antagonist; Helicobacter pylori infection; metronidazole resistance; proton pump inhibitor; triple therapy;
D O I
10.1097/00042737-200108000-00008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Eradication regimens combining two antibiotics with a proton pump inhibitor have been studied intensively. In contrast, only a few studies have focused on the possible role of H-2-receptor antagonists in eradication therapy. The mechanism involved in the synergy between antibiotics and proton pump inhibitors is still controversial. Objectives To compare the results of two triple-therapy regimens, different only in the antisecretory drugs used, in patients with Helicobacter pylori infection, and to assess the impact of primary resistance to metronidazole on treatment outcome. Methods A total of 120 patients with peptic ulcer and nonulcer dyspepsia were randomly assigned to a 2-week course of either: famotidine 40 mg twice a day, amoxycillin 1 g twice a day and tinidazole 500 mg twice a day (FAT group; n = 60); or omeprazole 20 mg twice a day, amoxycillin 1 g twice a day and tinidazole 500 mg twice a day (OAT group; n = 60). Upper endoscopy was performed prior to treatment and at least 4 weeks after completion of treatment and discontinuation of the antisecretory therapy. H. pylori status was assessed by a biopsy urease test, histology and culture. Results In the intention-to-treat analysis, eradication of H. pylori was achieved in 48 of the 60 patients (80%; 95% confidence interval: 70-90%) in the FAT group, compared to 50 of the 60 patients (83.3%; 95% confidence interval: 74-93%) in the OAT group. In the per protocol analysis, eradication therapy was achieved in 48 out of 53 patients (90.6%; 95% confidence interval: 83-98%) treated with FAT and 50 out of 57 patients (87.7%; 95% confidence interval: 79-96%) treated with OAT (not significant). The primary metronidazole resistance was present in 28.8% of strains. Overall, per protocol eradication rates in strains resistant and susceptible to metronidazole were 83.3% and 91.3% respectively (P > 0.05). Conclusions Two-week courses of either high-dose famotidine or omeprazole, both combined with amoxycillin and tinidazole, are equally effective for eradication of H. pylori infection. In a 2-week triple therapy, metronidazole resistance has no significant impact on eradication rates. Eur J Gastroenterol Hepatol 13:921-926 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:921 / 926
页数:6
相关论文
共 50 条
  • [41] The effectiveness and side effects of omeprazole, clarithromycin and tinidazole used in a community Helicobacter pylori eradication programme.
    Moayyedi, P
    Braunholtz, D
    Nathan, J
    Richards, IDG
    Dowell, AC
    Mason, S
    Axon, ATR
    GASTROENTEROLOGY, 1998, 114 (04) : A231 - A231
  • [42] An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively
    Miehlke, S
    Mannes, GA
    Lehn, N
    Hele, C
    Stolte, M
    Bayerdorffer, E
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) : 323 - 329
  • [43] Lactobacillus acidophilus administration added to omeprazole/amoxycillin-based double therapy in Helicobacter pylori eradication
    De Francesco, V
    Stoppino, V
    Sgarro, C
    Faleo, D
    DIGESTIVE AND LIVER DISEASE, 2000, 32 (08) : 746 - 747
  • [44] Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection
    Stark, CA
    Adamsson, I
    Edlund, C
    Sjosted, S
    Seensalu, R
    Wikstrom, B
    Nord, CE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (06) : 927 - 939
  • [45] A comparative trial of short term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication
    Caselli, M
    Ruina, M
    Fabbri, P
    Balhous, W
    Alvisi, V
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (04) : 849 - 850
  • [46] Profile study of side effects during triple therapy (omeprazole, amoxycillin, tinidazole) in 52 patients infected by Helicobacter pylori
    Delpre, G
    Livni, E
    Niv, Y
    GASTROINTESTINAL ENDOSCOPY, 1996, 43 (04) : 237 - 237
  • [47] Combination amoxycillin and metronidazole with famotidine in the eradication of Helicobacter pylori - a randomized, double-blind comparison of a three times daily and twice daily regimen
    Goh, KL
    Parasakthi, N
    Chuah, SY
    Toetsch, M
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (11) : 1091 - 1095
  • [48] No additional value of bismuthsubcitrate to combination omeprazole/amoxicillin therapy in the eradication of Helicobacter pylori
    Tan, ACITL
    denHartog, G
    Meijer, JWR
    Thies, JE
    deVries, RA
    Mulder, CJJ
    GASTROENTEROLOGY, 1996, 110 (04) : A273 - A273
  • [49] TREATMENT OF HELICOBACTER-PYLORI INFECTION WITH A COMBINATION OF ITRACONAZOLE AND OMEPRAZOLE
    KELLER, JJ
    VANDERHULST, RWM
    TYTGAT, GNJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1995, 9 (03) : 327 - 328
  • [50] AMOXICILLIN, CLARITHROMYCIN, ERYTHROMYCIN, ROXITHROMYCIN IN COMBINATION WITH OMEPRAZOLE FOR ERADICATION OF HELICOBACTER-PYLORI
    HALLBERG, H
    IDSTROM, JP
    JONSSON, A
    WRANGSTADH, M
    LIND, T
    GASTROENTEROLOGY, 1995, 108 (04) : A107 - A107